Price target lifted on Ascendis Pharma By: MarketMinute.com Stock News September 22, 2017 at 19:13 PM EDT Credit Suisse analyst Alethia Young lifted her price target on Ascendis Pharma (Nasdaq: ASND) from $30.00 to $50.00 sending the stock price soaring $6.50 to close at $34.24. Related Stocks: Ascendis Pharma ADR